Clinical Trial Update: Trial Utilizing Metronidazole to Optimize the Microbiome of Rectal Adenocarcinoma Undergoing Neoadjuvant Therapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial from MD Anderson Cancer Center is evaluating metronidazole to optimize the microbiome in rectal adenocarcinoma patients undergoing neoa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Adenocarcinoma

Drugs mentioned

• METRONIDAZOLE (Metronidazole)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Rectal Adenocarcinoma | Phase 2 | Status: RECRUITING